8 results about "Normal Sinus Rhythm" patented technology

A method for detecting signs of atrial fibrillation in normal sinus rhythm includes acquiring electrocardiogram data of a patient, generating preprocessed electrocardiogram data based on at least some specific regions from the electrocardiogram data, and determining a patient's risk of developing atrial fibrillation using the preprocessed electrocardiogram data and a pretrained atrial fibrillation determination model.

An artificial intelligence-enabled ECG algorithm system and method thereof are applied in the environment of the identification of patients with ventricular premature contractions (VPC) during sinus rhythm. The present invention of the artificial intelligence-enabled ECG algorithm system and method thereof can provide, a standard 10-second, 12-lead ECGs algorithm based on artificial intelligence for the identification of patients with ventricular premature contractions (VPC) during normal sinus rhythm; and, the ECG algorithm using artificial intelligence can detect some minimal changes in the patient's sinus rhythm ECG without VPC episodes, and can also identify patients having ventricular premature contraction for early treatment to reduce the patent's risk of heart failure or sudden death.

A method and apparatus for detecting onset of atrial fibrillation in a user's normal sinus rhythm based on a mobile ECG. [Solution] According to various embodiments, a method and apparatus for detecting signs of atrial fibrillation in normal sinus rhythm can be provided, the method and apparatus including the steps of acquiring electrocardiogram data of a patient, generating pre-processed electrocardiogram data based on at least a certain region in the electrocardiogram data, and determining the patient's risk of developing atrial fibrillation using the pre-processed electrocardiogram data and a pre-trained atrial fibrillation judgment model.

In one example, a cardiac monitoring system comprises a processor to receive a segment of an electrocardiogram (ECG) signal of a patient, and a memory to store the segment of the ECG. The processor is configured to identify QRS complexes in the segment of the ECG signal, generate a supraventricular (SV) template for SV complexes in the QRS complexes, identify SV complexes in the QRS complexes using the template, identify normal sinus rhythm (NSR) complexes in the segment of the ECG signal, obtain an atrial template for atrial waveforms in the NSR complexes, measure a range of a P-wave of the atrial waveforms from the NSR complexes, save the measured P-waves, and classify the identified SV complexes as either atrial fibrillation (AF) or supraventricular tachycardia (SVT) using the atrial template. Other examples and related methods are also disclosed herein.

The invention discloses a medicine for treating atrial fibrillation in an acute exacerbation stage of a chronic obstructive pulmonary disease and a preparation method of the medicine. The medicine is prepared from raw rhizoma coptidis, raw fructus gardeniae, lophatherum gracile, radix ophiopogonis, radix rehmanniae recen, lily, codonopsis pilosula, radix salviae miltiorrhizae, moutan bark, radix paeoniae rubra, semen boitae, spina date seeds, poria with hostwood and raw liquorice. The traditional Chinese medicine composition has the effects of clearing away heart fire and nourishing heart yin, has the effects of cooling and activating blood and clearing away heart fire and tranquilizing mind, and is suitable for atrial fibrillation in the acute exacerbation stage of chronic obstructive pulmonary disease, assisting in controlling the ventricular rate, preventing and treating thromboembolism and promoting the atrial fibrillation rhythm to be converted into sinus normal rhythm.

A medical device is configured to determine time intervals between successive cardiac events sensed from a cardiac electrical signal, to increase a value of a tachyarrhythmia interval count in response to each determined time interval that is detected as a tachyarrhythmia interval. The device is further configured to detect normal sinus rhythm events and to decrease the value of the tachyarrhythmia interval count in response to detecting a threshold number of normal sinus rhythm events.

Disclosed herein are implantable medical devices and systems, and methods for used therewith, that selectively perform atrial pacing at an atrial pacing rate that is faster than an intrinsic atrial rate of a patient while the patient is experiencing an atrial tachycardia or atrial fibrillation and the intrinsic atrial rate of the patient is within the specified range, to attempt to convert the arrhythmia to a normal sinus rhythm.